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Abstract: Open tetrapyrroles termed phycobilins represent the major photosynthetic accessory pigments of 
several cyanobacteria and some eukaryotic algae such as the Glaucophyta, Cryptophyta and Rhodophyta. 
These pigments are covalently bound to so-called phycobiliproteins which are in general organized into 
phycobilisomes on the thylakoid membranes. In this work we first briefly describe the physico-chemical 
properties, biosynthesis, occurrence, in vivo localization and roles of the phycobilin pigments and the 
phycobiliproteins. Then the potential applications and uses of these pigments, pigment-protein complexes and related 
products by the food industry (e.g., as LinaBlue® or the so-called spirulina extract used as coloring food), by the health 
industry or as fluorescent dyes are critically reviewed. In addition to the stability, bioavailability and safety issues of 
purified phycobilins and phycobiliproteins, literature data about their antioxidant, anticancer, anti-inflammatory, 
immunomodulatory, hepatoprotective, nephroprotective and neuroprotective effects, and their potential use in 
photodynamic therapy (PDT) are also discussed. 
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1. INTRODUCTION 
 Phycobilin is a term meaning ’algal bile’ (φύκος 
bilis, phycos bilis) and designates special open chain 
tetrapyrroles present as photosynthetic accessory pigments in 
several cyanobacteria and eukaryotic algal groups (i.e., 
Glaucophyta, Cryptophyta and Rhodophyta). Brilliantly blue 
extracts from Oscillatoria sp. containing phycobilins and 
showing red fluorescence were first described in the 19th 
century [1,2]. Such extracts were used for the first 
spectroscopic analyses and contributed to the development 
of fluorescence spectroscopy [3,4] and are still nowadays 
widely used as fluorescent dyes. 
Phycobilins and phycobiliproteins of photosynthetic 
organisms are used as natural colorants, coloring food, in 
dietary supplements and/or to prepare fortified and 
functional products [5,6]. Along with chlorophyllous 
pigments (reviewed in [5,7,8]), they are almost the only 
natural alternatives to greenish or bluish food colorants. In 
addition, phycobilin-containing products are also used in the 
health industry. 
In the present paper we first review the chemical and 
physical properties of phycobilins, their biosynthetic 
pathways, roles and occurrence in vivo. We also discuss the 
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applications of phycobilins and phycobiliproteins in the food 
industry along with their health benefits as well as problems 
related to their use, i.e., data about their stability, safety and 
toxicology. The global market value of phycobiliprotein 
products has been estimated to reach 60 million USD in 
2013 [9]. The size of this market is, however, expected to 
expand due to increasing consumer’s demand in natural blue 
and green food colorants and the nomenclatural and 
compositional problems surrounding the use of water-soluble 
chlorophyll (Chl) derivatives in the food industry. 
 
2. CHEMICAL AND PHYSICAL PROPERTIES OF 
PHYCOBILINS 
 
Phycobilins are open-chain (i.e., linear) tetrapyrroles 
and, in their chemical structure, similar to bilins in animal 
cells (reviewed in [10–12]). Phycobilins absorb light from 
the visible radiation range which is poorly absorbed by Chl 
[12], and thus allow organisms to live in deep-water niches. 
In Cyanobacteria, Glaucophyta and Rhodophyta, 
phycocyanins and phycoerythrins are the major 
phycobiliproteins containing the blue-colored 
phycocyanobilin and the red-colored phycoerythrobilin (Fig. 
1). The different color of the pigments is due to their 
different structures, i.e., phycoerythrobilin contains six 
conjugated double bonds and absorbs at lower wavelengths 
than phycocyanobilin that has eight conjugated double bonds 
[13]. 
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Fig. (1). Chemical structures of the major phycobilins. 
 
In addition, two more phycobilins, namely yellow-
colored phycourobilin, and purple-colored phycoviolobilin 
(also named cryptoviolin) were identified (reviewed in 
[14,15]). Phycobiliproteins of Cyanobacteria, Glaucophyta 
and Rhodophyta contain certain combinations of these four 
phycobilins and are organized into large supramolecular 
structure called phycobilisome (reviewed in [11,14–17]; 
further discussed in Section 4). In Cryptophyta, which do not 
have phycobilisomes, other bilins were found besides 
phycocyanobilin and phycoerythrobilin. The analysis of the 
Cryptophyta strain CBD led to the determination of the 
chemical structure of bilin 618 and bilin 584 (Fig. 1) both 
having acrylic acid side chain and differing in the number of 
conjugated double bonds [18]. In another strain, 15,16-
dihydrobiliverdin and 181,182-dihydrobiliverdin 
(mesobiliverdin) were identified [19]. The presence of 
various types of phycobilins differing in absorption 
characteristics contributes to the adaptation of Cryptophyta 
cells to individual environmental light conditions. 
Absorption properties of phycobilins are determined 
by their chemical structure, mainly by the number and the 
arrangement of conjugated double bonds (Fig. 1). In 
photosynthetic organisms, phycobilins are covalently linked 
to specific proteins and form together phycobiliproteins 
(further discussed in Section 4). The absorption properties of 
phycobiliproteins and hence the variety of colors observed in 
phycobilin-containing organisms depend on (i) the properties 
of chromophores, (ii) the linkage of phycobilins to proteins 
and (iii) the molecular organization of the phycobiliproteins, 
in particular, their aggregation state (thoroughly discussed in 
[11,14,15,20]). 
Concerning the chemical structure of phycobilins, 
four pyrrole rings are bound via single carbon bridges (Fig. 
1). Terminal rings (A and D) have oxygen atoms (as ketone 
groups) and sites forming bonds with proteins. The internal 
rings have propionate or acryloyl residues. Unlike Chls these 
compounds do not contain metal ions. Phycobilins are 
covalently bound to the biliprotein via one or two thioether 
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bonds [11,14]. In solution, when detached from the protein, 
bilins exist as mixtures of configurational, conformational, 
and tautomeric forms [11]. Photophysical properties of 
phycobilins have been summarized by [11]. In general, 
phycobilins absorb visible light within the 450-700 nm range 
and, to lower extent, the UV radiation between 300-400 nm. 
In solution, they show weak fluorescence because of 
conformational flexibility enabling efficient radiationless 
molecule relaxation. However, they become highly 
fluorescent when bound to phycobiliproteins [21], probably 
due to enhanced rigidity of the bilin molecule maintained in 
an extended conformation through interactions with the 
protein [22,23]. Application of biliproteins as fluorescent 
labels for studying protein dynamics [20] is discussed in 
Section 6.4. 
 
3. BIOSYNTHESIS OF PHYCOBILINS 
 
Tetrapyrrole biosynthesis is a multi-branched, 
conserved and precisely regulated metabolic pathway 
(reviewed in [24–29]) (Fig. 2). Metabolic intermediates as 
well as the enzymes catalyzing particular reactions of 
tetrapyrrole biosynthesis have been mostly recognized 
(reviewed in [25,29–36]). 
 
 
Fig. (2). Overview of phycobilin biosynthesis and its relation to chlorophyll and heme biosynthesis. Abbreviations: ALA, 5-
aminolevulinic acid; PROTO IX, protoporphyrin IX. 
 
The biosynthesis of phycobilins proceeds via the 
heme biosynthetic pathway and coincides with Chl 
biosynthesis until the stage of protoporphyrin IX (PROTO 
IX) formation (reviewed in [7,10,15,37]). The chelation of 
PROTO IX backbone with Fe2+ ion leading to protoheme 
synthesis is the initial reaction of the Fe-branch of 
tetrapyrrole synthesis (Fig. 2), and protoheme is the direct 
substrate for phycobilin synthesis [38,39]. The synthesis of 
phycobilins starts with the opening of the protoheme 
macrocycle releasing Fe2+ and carbon monoxide [40,41]. 
This reaction is catalyzed by heme oxygenase ([42], 
reviewed in [43,44]). Algal heme oxygenase was first 
characterized for Cyanidium caldarium as soluble and 
ferredoxin-dependent plastid enzyme [45–47], which was 
confirmed for Synechocystis [48] and plants [49]. The 
reaction consumes three O2 molecules [37,50]. 
Biliverdin IXα, which is the product of the reaction 
catalyzed by heme oxygenase, is then reduced to form 
phycobilin molecules. Reduction of one or more double 
bonds of the outer rings of biliverdin IXα is catalyzed by 
enzymes belonging to ferredoxin-dependent bilin reductases 
(FDBR) [46]. To date, six classes of FDBR have been 
described (reviewed in [50,51]). Among reductases involved 
in phycobilin synthesis, phycocyanobilin:ferredoxin 
oxidoreductase (PcyA) is present in all cyanobacteria and is 
biochemically well characterized. It catalyzes the transfer of 
four electrons from ferredoxin to two distinct double bonds 
of biliverdin IXα, leading to the formation of 
phycocyanobilin via 181,182-dihydrobiliverdin 
(mesobiliverdin) as intermediate [50,52]. Similarly, 
phycoerythrobilin synthase (PebS, present in marine 
cyanophages) catalyzes the two-step transfer of four 
electrons from ferredoxin to two distinct double bonds of 
biliverdin IXα to form phycoerythrobilin via 15,16-
dihydrobiliverdin. In cyanobacteria, 15,16-
dihydrobiliverdin:ferredoxin oxidoreductase (PebA) 
transfers two electrons to biliverdin IXα to form 15,16-
dihydrobiliverdin, which can be then converted to 
phycoerythrobilin due to another two-electron reduction 
catalyzed by phycoerythrobilin:ferredoxin oxidoreductase 
(PebB) [50,52]. However, the exact distribution of different 
classes of phycobilin reductases among various groups of 
photosynthetic organisms is beyond the topic of this article 
and is discussed elsewhere [50,51]. The last step in 
phycobiliprotein biosynthesis is the binding of phycobilins to 
specific apoproteins, which is either spontaneous or 
catalyzed by specific lyases (reviewed in [20,50]). Three 
classes of lyases have been recognized till now. One class of 
lyases (i.e., E/F-type lyases) also plays an additional role in 
the modification of phycobilin pigments during the 
attachment reaction, leading to the formation of 
phycoviolobilin and phycourobilin [20]. 
 
4. OCCURRENCE, LOCALIZATION AND ROLES OF 
PHYCOBILINS IN VIVO 
 
Phycobilins are involved in capture of light for 
photosynthesis as accessory pigments absorbing and 
transferring sunlight energy from the antennae towards the 
reaction centres. Phycocyanobilin (also termed 
phycobiliverdin), phycoerythrobilin and less typically 
phycourobilin [53,54] and phycoviolobilin [51,55] 
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commonly termed phycobilins are the only tetrapyrrole 
accessory pigments of (most) cyanobacteria (except 
prochlorophytes which have Chl b as accessory pigment and 
no phycobilins), glaucophytes and red algae. Cryptophyta 
contain both phycobilins and Chl c as accessory pigments, 
however, their phycobilins are differently organized and 
localized than those of the other organisms mentioned above. 
Similarly to Chls, phycobilin pigments are also bound 
to proteins located to the thylakoid membranes present either 
in the cytoplasm (in prokaryotic cyanobacteria) or in the 
chloroplasts (in case of eukaryotes) [56]. 
Open tetrapyrroles have important roles in the 
metabolism of photoautotrophic organisms. In plants, such 
molecules are present in low amounts as pigments bound to 
proteins (e.g., in phytochrome photoreceptors) and play 
crucial roles in plant morphogenesis and development [57]. 
However, in cyanobacteria, red algae, glaucophytes and in 
cryptophytes, open chain tetrapyrroles (phycobilins) 
involved in photosynthesis are abundant enough to mask the 
Chl molecules and carotenoids and confer their color to the 
whole organism [58]. Blue colored phycocyanobilin and red 
colored phycoerythrobilin are commonly found phycobilins 
present in large amounts, while orange-yellow phycourobilin 
[54] and purple phycoviolobilin (also termed cryptoviolin 
and phycobiliviolin) [51,55] are rarely occurring pigments, 
the latter serving as the photoreceptor pigment in 
cyanobacteriochrome involved for instance in the regulation 
of cyanobacterial phototaxis [51,55]. 
In situ, the ring A (or sometimes also ring D) of 
phycobilins (Fig. 1) are covalently bound to specific cystein 
groups of different hydrophilic proteins (called 
phycobiliproteins and also chromoproteins) via thioether 
linkage [59]. In cyanobacteria and red algae, 
phycobiliproteins are formed by two subunits forming a 
basic αβ heterodimer, that has been shown to aggregate into 
(αβ)3 trimers (e.g., in allophycocyanin) or (αβ)6 hexamers 
(phycocyanin and phycoerythrin) acquiring ring structures 
[53,54,60]. Phycobiliproteins bind different numbers of the 
distinct phycobilin molecules: allophycocyanins and 
phycocyanins bind phycocyanobilin, while phycoerythrins 
bind phycoerythrobilin or sometimes also phycourobilin. 
Due to their distinct molecular environment, the phycobilin 
pigments of the three phycobiliproteins absorb different 
wavelengths of visible light and have thus different colors. 
Allophycocyanin is bluish green (bright aqua blue color), 
phycocyanin is dark cobalt blue, and phycoerythrin is purple 
(bright pink), with absorption and fluorescence emission 
maxima at 650-655 nm/~660 nm, 610-620 nm/~637 nm and 
540-570 nm/~577 nm, respectively [59,61]. In addition, the 
major classes of phycocyanins and phycoerythrins also 
contain different phycobiliprotein-pigment complexes. They 
may be artificially classified as C- and R-phycocyanin, 
present in cyanobacteria and red algae, respectively, R-
phycocyanin obtained from Synechococcus, C-phycoerythrin 
present in cyanobacteria, B- and R-phycoerythrins in red 
algae. These have slightly different absorption characteristics 
due to slight differences in their structure [60,62–64], 
however, detailed discussion of these forms is beyond the 
scope of this review. Orange-colored phycoerythrocyanin 
pigment-protein complexes binding phycoviolobilin and 
phycocyanobilin pigments and present in light-harvesting 
antennae of some cyanobacteria can be also distinguished 
with absorption and fluorescence emission maxima at ~575 
nm/~607 nm [61,65] but are far less studied, and will be, 
therefore, not discussed in detail. 
Cryptophyta have unique phycobiliprotein dimers in 
the thylakoid lumen [66,67], while the phycobiliproteins of 
cyanobacteria, red algae and glaucophytes form large 
supramolecular aggregates – the so-called phycobilisomes 
(Fig. 3) – on the outer surface of the thylakoid membranes 
(or in few cyanobacteria also on the inner surface of the 
plasmamembrane). These phycobilisomes consist of a 
central core composed of allophycocyanin (located in the 
close vicinity of Chl a during photosynthesis) and peripheral 
rods composed of phycocyanin and phycoerythrin hexamers 
(the latter are absent in some species, but are normally 
located at the periphery of the phycobilisomes) stacked on 
the top of each other [13,53,68] and held together by several 
linker polypeptides that optimize light absorption and energy 
transfer within the phycobilisomes [20,69,70]. The pigments 
of phycobiliproteins have overlapping absorption and 
emission spectra that allow a non-radiative, direct and 
efficient transfer of the excitation energy among them along 
an energy gradient from the rods towards the photosystem II 
(PSII) core and partially to photosystem I (PSI) core [53,54]. 
In addition, to the phycobiliproteins discussed above, 
phycobilisomes are also structurally and spectroscopically 
well characterized light-harvesting antenna complexes, 
which absorb visible light in the 550-650 nm spectral region 
[59]. It may be noted, that several algal species (e.g., 
Galdieria red algae) are able to grow under heterotrophic 
and mixotrophic conditions, and when depleted in nitrogen, 
they dismantle their phycobilisomes and proteins using them 
as nitrogen source [71,72]. 
 
 
Fig. (3). Schematic representation of a hemidiscoidal 
phycobilisome located on the thylakoid membrane, in close 
connection with photosystem II (PSII). The phycobilisome 
consists of a three cylindrical allophycocyanin (APC) core 
and six lateral cylinders formed by phycocyanin (PC) and 
phycoerythrin (PE) hexamers. 
 
Obviously, the light phase of photosynthesis and the 
photosynthetic pigments are located to thylakoids (or in 
some cyanobacteria to the plasma membrane), and the dark 
phase proceeds in either the cytoplasm (in case of 
prokaryotic photosynthetic organisms) or in the stroma of 
Phycobilins in Food Industry and Medicine Mini-Reviews in Medicinal Chemistry, 2016, Vol. 0, No. 0    5 
plastids (in eukaryotes) [59]. Phycobilisomes present at the 
membrane surface (Figs. 3 and 4) prevent the assembly and 
stacking of thylakoid membranes. Therefore, Cyanobacteria, 
Glaucophyta and Rhodophyta (Fig. 4) have single, unstacked 
thylakoids [53,56]. However, due to the absence of 
phycobilisomes, the thylakoids of Cryptophyta are parallelly 
arranged into bilayered lamellar assemblies without 
connection between the adjacent bands of two thylakoids 
[53,56]. 
 
 
Fig. (4). Chloroplast containing single thylakoids with 
lightly stained phycobilisomes in the freshwater rhodophyte, 
Compsopogon caeruleus. Micrograph courtesy of Joe Scott, 
College of William and Mary, Virginia, United States. S: 
stroma; white arrowhead: phycobilisome on the thylakoid 
surface. Bar: 1 µm. 
 
5. SOURCES FOR INDUSTRIAL EXTRACTION 
 
Not phycobilin pigments alone, but their water-
soluble protein-bound forms (phycoerythrin, 
allophycocyanin and phycocyanin) are in general used by the 
industry for different applications (see Section 6, reviewed 
by [13,61,64]). These may be obtained – along with Chls and 
carotenoids - from cell cultures of different cyanobacteria 
and red algae (e.g., phycoerythrin and phycocyanin from the 
cyanobacteria Arthrospira platensis and Arthrospira 
maxima, phycoerythrin from the red alga Porphyridium 
cruentum, and phycocyanin from the red algae Porphyridium 
aerugineum and Galdieria sulphuraria or the cyanobacteria 
Oscillatoria quadripunctulata or Anabaena [13]) grown in 
bioreactors or different cultivation systems [13,64] (Fig. 5). 
For an updated review about microalgal sources for 
phycobiliprotein extraction see [73]. Up to 40% of the 
proteins of Arthrospira cells is phycocyanin [74]. However, 
extraction from cyanobacteria is not simple due to their 
special multilayered cell wall and the presence of 
contaminants, therefore, extraction usually results either in 
high purity or high efficiency. Isolation consists typically of 
two phases: (1) liberation of intracellular content by 
pretreatment to yield a crude extract (i.e., by precipitation, 
centrifugation, or other treatments including microwave- or 
ultrasound-assisted extraction [75,76]), (2) 
isolation/purification step(s) that separate the pigment-
protein complexes by conventional methods [5,13,61,73,77–
81]. 
 
 
 
Fig. (5). Open ponds used for microalga cultivation (upper 
panel) and microscopic image showing spirulina (lower 
panel) (photo courtesy to DIC Corporation). 
 
Phycocyanin is mostly extracted from Arthrospira 
[79,81–83] (Fig. 5, lower panel). After extraction a 
combination of gel adsorption and ion exchange 
chromatography can be used for purification. However, 
simpler (one-step), faster and more cost-efficient purification 
protocols are under development for this species (e.g., 
[13,81]), and extraction and purification from other species 
were also reported (e.g., [77,84], reviewed in [64]). Pure 
phycoerythrin can be obtained from the unicellular red 
microalga, Porphyridium cruentum [77], but protocols for 
other red micro- or macroalgal species have been also 
reported [85–88]. The use of anionic chromatographic 
column of DEAE cellulose seems to represent cost-effective 
large preparative technique for purification [77]. However, it 
has to be noted, that the calculated unit production costs of 
phycobiliprotein extraction and production (approx. 30,000-
60,000 USD per kg in 2004 [77]) results in very high market 
price (for pure phycobiliproteins, e.g., 5000-33,000 USD per 
g in case of Cyanotech products mostly in the form of 
fluorescent dyes in 2008 [61], and similarly high market 
price is typical also nowadays for these compounds). This is 
still quite expensive for food industry applications where 
relatively large quantities: e.g., 50-100 mg kg-1 and 140-180 
mg kg-1 phycoerythrin and phycocyanin, respectively, are 
required to color food or beverages [89]. Therefore, further 
developments such as e.g., expanded bed adsorption 
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chromatography [90–92], or methods allowing simultaneous 
recovery of different phycobiliproteins [79] are needed. 
Similarly, the efficiency of different extraction and 
isolation/purification steps using dry or wet biomass must be 
also carefully compared and optimized [13,64,93]. In 
addition, special care has to be taken during extraction and 
isolation (and also during subsequent use) to preserve the 
stability of the phycobiliprotein complexes [94], therefore, 
the temperature and pH values of extraction have to be 
carefully chosen [95] (see Section 6.1). 
It is noteworthy to mention, that the food industry 
actually uses a so-called semi-purified spirulina extract to 
color food instead of highly expensive purified 
phycobiliproteins (see Section 6.2). The term spirulina is 
also used to designate the protein-rich dried algal (in fact 
cyanobacterial) biomass used as nutritious food and/or 
dietary supplement for humans. This persisting term 
(’spirulina’) is based on a confusion, because although the 
edible cyanobacterial species used for its production are 
Arthrospira maxima and A. platensis, earlier they were often 
misidentified as Spirulina maxima and S. platensis that are in 
fact not used for the production of the so-called spirulina 
food colorant [96]. During large-scale production of 
spirulina, considerable amounts of inferior quality spirulina 
are obtained due to the presence of biotic and abiotic 
stressors (contamination with microorganisms or heavy 
metals) [91]. Low-quality spirulina is not suitable for direct 
human consumption but may be used as source for the 
isolation and purification of phycobiliprotein food colorants 
or other dyes [91]. 
 
6. PHYCOBILINS AND PHYCOBILIPROTEINS AS 
HIGH VALUE COMPOUNDS 
 
Phycobilins may be used by the food industry and in 
medicine. Several companies deal with phycobilins (more 
exactly with phycobiliproteins): there is a great number of 
patents related to their production, to their applications in 
medicine, food and other areas (e.g., cosmetic industry), but 
most patents are related to their use as fluorescence dyes in 
clinical and immunological analyses [13,61]. However, there 
are several parameters – for instance the stability of the 
pigments – that have to be carefully considered before the 
potential industrial applications, and which will be thus first 
reviewed in Section 6.1. 
 
6.1. Stability 
 
Purified phycobiliproteins (i.e., pigment-protein 
complexes containing various proteins and phycobilins) are 
considered for industrial applications. There are 
contradictory data about the stability of phycobiliproteins, 
however, their stability varies among the distinct proteins 
and is also strongly influenced by pH [79,97], temperature 
[97,98], protein concentration, osmotic and ionic strengths 
[98], and the used purification methods, which may or may 
not dissociate the hexamers and/or other aggregates [63,99]. 
Several studies have shown that purified phycocyanin 
[74] and other phycobiliproteins, e.g., allophycocyanin 
[79,100] remain stable (or at least do not get completely 
denaturated) over a large pH range (e.g., between pH 4-9 
[79] or 7-10 [74,100]). Phycoerythrin has stable and long 
shelf life at pH 5-6 [89], especially when stored dry. 
Similarly, phycocyanin-colored dry food retained its color 
for more than 4 years [89]. Another advantage of 
phycobiliproteins – for instance when compared with 
anthocyanins – is that their color does not change with pH. 
Phycocyanin is insoluble in acidic solution below pH 
3, and is in general sensitive to light and heat stress (i.e., 
protein denaturation occurs above 45 °C resulting in color 
change) [101]. However, degradation processes depend on 
the pH and the structure of the phycobiliprotein (e.g., 
cyanobacterial phycocyanin may be less stable than C-
phycocyanin from Porphyridium) [89]. Denaturation and 
bleaching of the phycobiliproteins and various phycobilin 
pigments have been shown to occur after several minutes of 
heat treatment at 60–65 °C in vivo in cyanobacterial and red 
algal cells, while virtually no alteration occurred in Chl or 
carotenoid absorption [98]. Similar phenomenon can be 
observed when the typical black color of dried laver (nori, 
Porphyra sp.) turns green when toasted and this color 
remains during storage for few days in vinegar [5,102]. 
However, sometimes undesirable reddish-brown coloration 
appears due to monomerization of phycoerythrin at low pH 
in vinegar and/or in vivo in cultivated nori when the fronds 
on frozen nursery-nets become damaged [103]. Interestingly, 
phycocyanin and phycoerythrin isolated from Porphyridium 
remain stable for 40 or 30 minutes, respectively, to heat 
stress (up to 65 °C) at lower pH values (pH 4-5-6) in vitro 
[89], and sorbitol can to some extent prevent the 
temperature-induced degradation of the protein, and thus the 
decoloration of phycocyanin [104]. 
Strong conditions (i.e., 1 M sodium perchlorate and 
sodium thiocyanate) are in general needed to produce 
monomeric biliproteins, but even these conditions are not 
necessarily dissociating the monomers into their subunits 
[105]. On the other hand, temperature-induced bleaching of 
the pigments (occurring at 60-65 °C within few minutes) 
could be prevented in isolated phycobilisomes in the 
presence of high phosphate concentrations [98], indicating 
the complexity of the interactions determining 
phycobiliprotein stability. Evidently, in the presence of SDS 
(1 mM) and other detergents (1.6-6.4 M urea) phycocyanin 
and allophycocyanin get denaturated. 
In spite of the above-mentioned instabilities of 
phycocyanin, it seemed to be the most versatile blue food 
colorant in exploratory studies comparing indigo, gardenia 
blue and phycocyanin in soft drink, jelly gum, hard candy 
and coated soft candies [101]. 
 
6.2. Use as Food Color Additives (Linablue® and 
Spirulina Extract) 
 
Open chain tetrapyrroles are potentially interesting 
for future food and nonfood industries as natural coloring 
agents in their water-soluble protein-bound forms [106]. In 
addition to enhanced solubility, these are also highly stable 
in the pH range of 4 to 9 [79]. Phycoerythrin has red color 
and may be considered as alternative red natural food 
coloring even in pH ranges where for instance anthocyanins 
are no longer red. In addition, phycoerythrin has yellow 
fluorescence that may be exploited in some new food 
Phycobilins in Food Industry and Medicine Mini-Reviews in Medicinal Chemistry, 2016, Vol. 0, No. 0    7 
products (candies, cake decorations, lollypops fluorescing 
under UV, alcoholic beverages fluorescing at pH 5-6) 
[61,80], and it can be also incorporated to microemulsions of 
aerosols [63]. However, its shelflife for instance in alcoholic 
beverages is short [89]. 
More importantly, allophycocyanin and phycocyanin 
have bluish green and dark cobalt blue colors, respectively, 
hues which cannot be reproduced by almost any other 
natural coloring agent (with the exception of Chls and their 
derivatives, gardenia blue, indigo and marennine) 
[6,7,80,101]. However, comprehensive knowledge and 
technological base for augmenting the commercial utilities 
of phycobiliproteins is still lacking and several of their novel 
applications are reported only in patents (reviewed in [61]). 
Phycobiliprotein colorants (especially phycocyanin) 
are considered non-toxic and non-carcinogenic and are used 
as blue colorants in some countries (e.g., in Japan, Australia 
[96], Thailand and China [81]) to color cosmetics (like 
lipstick and eye liners) [107] and food such as fermented 
milk products, ice creams and sorbets, popsicles, milk shakes 
and desserts, other dairy products, sweet cake decorations, 
chewing gum, candies, wasabi, different soft and alcoholic 
beverages [61]. Phycocyanin (isolated from Arthrospira) 
was first marketed under the brand name Linablue® by 
Dainippon Ink & Chemicals Inc. (Japan, current name: DIC 
Corporation) in 1977-1980 [108] (Fig. 6). 
 
 
 
Fig. (6). LinaBlue® powder and solution in water (photo 
courtesy to DIC Corporation). 
 
Due to the increasing need to replace artificial blue 
food colors, the phycobilins present in the so-called 
’spirulina extract’ (or simply spirulina) obtained by filtered 
aqueous extraction from the dried biomass of Arthrospira 
platensis cells have been recently accepted for safe use in 
candy (e.g., blue M&M’s) and chewing gum as a color 
additive in the United States since 2013 on demand of Mars, 
Inc. [109,110]. In 2014, the use of spirulina extracts at levels 
consistent with good manufacturing practice (GMP) has 
been extended to several products (fermented milk products, 
yogurts, milk shakes and desserts, puddings, other dairy 
products, ice creams, sorbets, popsicles, frostings and other 
frozen desserts, sweet cake decorations, dessert coatings and 
toppings, custards, gelatin, breadcrumbs, ready-to-eat 
cereals, cottage cheese, different soft and alcoholic 
beverages) [111] and to coating formulations applied to 
dietary supplements and drug tablets and capsules in 2015 
[112]. Evidently, these contain all kinds of water-soluble 
components present in Arthrospira cells (e.g., other proteins, 
polysaccharides, vitamins, minerals, etc.) [109], therefore, 
special care has to be taken to avoid any contamination with 
cyanobacterial toxins and/or heavy metals. The originally 
regulated spirulina extract – as specified by the Federal 
Register – contained not less than 10% phycocyanin [109], 
but later other regulations came up that allowed differently 
processed spirulina food colorants containing not more than 
2% [111] or up to 28% [112] phycocyanin (the latter is 
obtained in an aqueous extract obtained from spray-dried 
biomass). 
According to the new European Union guideline on 
foods, food ingredients and flavorings with a secondary 
coloring effect (also termed ’coloring foodstuff’ - reviewed 
by [113]), spirulina extract can be used as clean label without 
E-number in the European Union. As a consequence of these 
regulations, a 7-10fold expansion of the global market of 
spirulina-derived natural blue food colorants is expected. 
Spirulina is generally recognized as safe (GRAS) when used 
as food ingredient at quantities not higher than 0.5 to 3 g per 
serving [108]. In addition to use as human food, spirulina 
may be added to animal feed as well as additive. 
 
6.3. Health Promoting and Medicinal Effects 
 
Techuitlatl (blue gold) of the lake Texcoco in Mexico 
is in fact concentrated Arthrospira (spirulina) which has 
been known and consumed by Aztecs as a sort of dry cake 
since the pre-Columbian America (1300 A.D.) [114]. 
Similarly, different tribes in Sahara (especially Kanembu 
populations in Chad and Niger) used and still use the same 
species under the name dihé as healthy food rich in proteins 
and provitamin A [115], and recently FAO has also 
recognized spirulina as effective alternative to fight 
malnutrition and as animal feed [108]. Arthrospira or other 
cyanobacterial products (including those produced on the 
basis of Aphanizomenon flos-aquae – e.g., [116,117]) may 
be used as functional food due to their antioxidant, 
antimicrobial effects and fatty acid content [13,61]. There 
are several reports and reviews (e.g., [5,13,115]) about the 
potential health benefits (e.g., [118,119]) or toxicological 
studies of spirulina extraxts (proving its safe use as food, 
food colorant and food supplement). 
However, in this Section the toxicology and potential 
health/medicinal effects and applications of phycobilins and 
phycobiliproteins are discussed. For further details about the 
roles of dietary phycocyanin [60,99] and phycobiliproteins 
[120] in animals and humans the readers are directed to the 
above-mentioned reviews [60,99,120]. 
Medicinal studies with phycobilins should preferably 
use a single compound with verified purity and/or with 
stable and well-characterized composition. However, often 
this is not the case: several studies use ’spirulina’ extract or 
dry powder in experiments, although the phycobilin and 
phycobiliprotein composition of these products greatly vary, 
not to speak about the low digestibility of algal cells and the 
presence of several other biologically active compounds in 
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these extracts (e.g., Chls, carotenoids, lipids, etc.) (Fig. 7). 
Due to the presence of a complex mixture of different 
biologically active compounds, their different 
bioavailabilities, metabolization and biological effects as 
well as their synergistic or antagonistic effects it is difficult 
to clearly evaluate and compare literature data in such cases. 
Therefore, studies dealing with the standardization of 
the growth conditions of organisms containing such 
commodities and of the commodities themselves are of great 
importance, and we decided to focus in this review on data 
dealing with purified phycobilins or phycobiliproteins. 
Oxidative stress (ROS formation and lipid 
peroxidation), apoptosis and inflammatory processes are key 
players in many diseases, however, often several of them 
occur simultaneously. Therefore, the thematic grouping of 
the data below is only an attempt to overview literature data 
related to most important and characteristic effects of the 
different phycobiliproteins. Recent reviews summarizing in 
vitro and in vivo therapeutic potential of phycocyanin by 
separately discussing the different organs and cells are also 
available [60,99]. 
 
 
Fig. (7). Different fractions of bioactive components 
obtained from dried spirulina powder from left to the right: 
carotenoids (yellow fraction with β-carotene and zeaxanthin 
as main components), chlorophyll a (green), phycocyanin 
(LinaBlue®, blue), hot water extract from spirulina 
consisting of polysaccharides (brown) (photo courtesy to 
DIC Corporation). 
 
6.3.1. Bioavailability and Safety 
No cytotoxicity of phycocyanin was shown in vitro in 
mouse myeloma cell cultures incubated with phycocyanin, 
but toxicity could be induced by simultaneous photodynamic 
therapy (PDT), i.e., using laser irradiation of the same cells 
[121]. At the same time, colony forming assays with 
phycocyanin isolated from Microcystis and used for PDT 
have demonstrated that the cytotoxicity of phycocyanin is 
much lower on normal HL7702 liver cell lines than on 
HepG2 tumor cells [122]. Similarly to phycocyanin, no in 
vitro cytotoxicity of phycoerythrin was observed in the three 
human cell lines studied [123]. 
In these in vitro models, phycobiliproteins have been 
shown to enter the cells [124–127] and even mitochondria 
[122]. However, some of these studies treated the cells with 
saponin to permeabilize the cell membrane allowing the 
uptake of the polyclonal antibodies [122,124]. In addition, 
orally administered phycobiliproteins must suffer 
degradation in the gastrointestinal tract and, thus, probably 
their lower molecular weight metabolites are involved in the 
observed in vivo pharmacological effects [99]. For instance, 
such metabolites have been shown to cross the hemato-
encephalic-barrier where they exerted their neuroprotective 
effect [128]. It may be noteworthy to mention in this context 
that the in vitro antioxidant activity of phycocyanin was 
retained even after trypsin digestion [74]. 
The effective dosage of orally administered 
phycocyanin varies from 25 to 300 mg kg-1 in animal models 
of inflammation [99,129]. However, no toxicity, no adverse 
effects and no mortality have been reported during 
subchronic (5 mg phycoerythrin kg-1 b.w./day [123]) and 
acute toxicity tests of phycocyanin in rats [123,130,131] and 
mice [130,132] even at 2000 [123], 3000 [130] or 5000 
[131,132] mg kg-1 oral administration. In addition to these no 
observed adverse effect levels (NOAEL) during oral feeding, 
intraperitoneal administration of 70 mg kg-1 [133] and even 
200 mg kg-1 [134] phycocyanin also had no adverse effect in 
rats. 
These data indicate that phycobiliproteins may be 
considered as potentially safe drugs and photosensitizers, 
although of course further metabolic, preclinical 
pharmacological and toxicological studies are needed to 
confirm this hypothesis. The pharmacokinetics and 
metabolism of phycobiliproteins must be also thoroughly 
characterized before eventual clinical trials. 
 
6.3.2. Antioxidant Effect 
Many diseases (i.e., neurodegenerative and 
inflammatory diseases, atherosclerosis, cancer, diabetes 
mellitus, reperfusion injury), and aging processes are 
induced and/or accompanied by oxidative stress. 
Unfortunately, in these cases the organism’s own antioxidant 
defense system cannot counteract the excessive formation of 
free radicals, but disease may be prevented or the symptoms 
and/or effects may be alleviated by the therapeutic use of 
different antioxidants. The structure of phycobilins 
(especially phycocyanobilin) is similar to that of bilirubin, a 
potent antioxidant and ROS scavenger in vivo. This may 
explain – at least partly – the strong biological activity of 
phycobilin pigments and of the phycobiliproteins binding 
such pigments. 
Most studies dealing with the antioxidant effects of 
the different phycobiliproteins were carried out using 
isolated phycocyanin (especially C-phycocyanin, a complex 
containing only phycocyanobilin) and/or its pigments, both 
extracted from Spirulina species, while much fewer studies 
concentrated on allophycocyanin (e.g., [100,135–137]) 
and/or phycoerythrin (e.g., [137–139]), the latter being used 
first of all as fluorescent dye (see Section 6.4). 
Various in vitro and in vivo studies have confirmed 
that phycocyanin and phycocyanobilin are efficient 
scavengers of ROS [140]. For instance, phycocyanin 
scavenges hydroxyl [140–144], alkoxyl radicals [141], and 
peroxyl radicals [117,142–147], singlet oxygen [144,148], 
hydrogen peroxide [144,147], superoxide anions [144], 
hypochlorous acid [143,144,149] and reactive nitrogen 
species (RNS) such as peroxynitrite [144,150] and nitric 
oxide [151]. Phycobiliproteins (especially Se-containing 
phycocyanin) are also able to scavenge non-natural radicals 
(like e.g., 2,2-azinobis(3-ethylbenzothiazolin-6-sulphonic 
acid) [152,153]. Phycocyanin protected human erythrocytes 
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[145] and rat liver microsomes against lysis caused by 
peroxyl and hydroxyl radicals [154] and inhibited lipid 
peroxidation in rat liver microsomes [141], in human and rat 
erythrocytes [116] and in carbon tetrachloride-induced rat 
liver in vivo [154]. Similarly, phycocyanin alleviated 
paraquat-induced acute lung injury in rats via alleviation of 
the earlier inflammation damage caused by paraquat-induced 
oxidative stress [155]. 
Most in vitro and in vivo studies have used purified 
phycobiliproteins, however, some studies separately tested 
and compared the antioxidant capacities of the functional 
pigment-protein complexes (e.g., phycocyanin) and of the 
chromophore pigment (e.g., phycocyanobilin) alone. For 
instance, in vitro studies have shown that phycocyanin 
isolated from Spirulina platensis is a more effective 
peroxynitrite scavenger than phycocyanobilin [150], while 
phycocyanobilin from Aphanizomenon flos-aquae proved to 
be a more effective peroxyl radical scavenger than 
phycocyanin from the same species [117]. In another in vitro 
study, phycocyanobilin was shown to be mostly responsible 
for the antioxidant activity of phycocyanin isolated from 
fresh or spray-dried Spirulina platensis against oxidation of 
methyl linoleate in a hydrophobic system or in 
phosphatidylcholine liposomes [156]. Obviously, the 
phycocyanobilin pigment(s) present in the phycobiliprotein 
complexes are involved in the process of ROS scavenging 
[142,146,148,152,154,157] as demonstrated clearly by their 
radical assisted bleaching during this process [142,148,154]. 
For instance, singlet oxygen and peroxyl radicals are 
stabilized by oxidizing the double bond of the tetrapyrrole 
[142,144,149]. However, heterologously expressed 
allophycocyanin apoprotein and even its subunits were 
shown to inhibit hydroxyl radicals [135], and both 
phycocyanobilin and the recombinant apoprotein were 
shown to take part in the quenching of singlet oxygen [148]. 
Similarly, both the native phycocyanin and the recombinant 
phycocyanin apoprotein (β subunit) were able to scavenge 
peroxyl radicals and hydrogen peroxide and to protect 
erythrocytes from oxidative damage, although the latter was 
less effective [147]. 
Selenium-containing allophycocyanin also inhibited 
ROS generation, and, thus attenuated the oxidative stress 
induced by 2,2’azobis(2-amidinopropane) dihydrochloride in 
human erythrocytes [158]. Similarly, selenium-containing 
phycocyanin showed stronger antioxidant activity 
(superoxide and hydrogen peroxide radical-scavenging 
[152]) than phycocyanin in several in vitro assays [152,153]. 
Other works have shown that natural allophycocyanin 
[100] or phycocyanin [74,159] complexes isolated from 
Spirulina platensis have photodynamic effect [159] and can 
generate hydroxyl radicals in light (when excess excitation 
energy is absorbed but not properly allocated in them in the 
absence of the electron transport chain), but scavenge the 
same radicals in darkness (due to their antioxidant 
properties) [74,100]. Denaturation of the allophycocyanin 
[100] or phycocyanin [74] complexes by different agents 
lead to the disruption of the hydroxyl radical generating 
capacity in the light and at the same time increased the ROS 
scavenging activity, probably by exposing antioxidant parts 
of the complexes (i.e., the chromophores) to the environment 
containing the ROS. Trypsin digestion of the phycocyanin 
apoprotein demonstrated that the apoprotein itself also has 
antioxidant properties [74]. Methionine and cysteine 
[160,161] (and other) amino acid residues of the protein may 
contribute to its antioxidant effect (for instance hypochloric 
acid scavenging) [149] as demonstrated also by studies on 
isolated phycocyanin peptides [161]. Red light illumination 
of phycocyanin caused bleaching of phycocyanobilin due to 
the singlet oxygen production induced by the irradiation of 
the bilin group [148]. On the other hand, blue light increased 
the in vitro scavenging effect of phycocyanin due to changes 
induced in the conformation of the protein (altering the 
localization of cysteine residues potentially involved in ROS 
scavenging) [160,161]. 
Taken together, these data show that both the open 
tetrapyrrole chromophores (e.g., [142,146,148,157]) and the 
phycobiliproteins (apoproteins and potentially their 
degradation products formed in the gastrointestinal tract, see 
Section 6.3.1) (e.g., [135,147,152]) have antioxidant effects 
by scavenging ROS and inhibiting lipid peroxidation [143]. 
In addition, phycocyanin can also chelate iron ions 
[129,143], which are involved in many processes leading to 
the formation of free radicals and radical-mediated cell 
death. Therefore, phycobiliproteins may be used in the 
treatment of various conditions which are aggravated by 
ROS and in which iron is implicated like several 
neurodegenerative disorders (Alzheimer’s and Parkinson’s 
disease) [129]. Furthermore, the antioxidant activity of 
phycobiliproteins may also be associated with their chelating 
potential. 
The strong antioxidant capacity of these compounds 
may explain, at least in part, their anti-inflammatory, 
anticancer and hepatoprotective effects. At the same time, 
their capacity to generate ROS upon light exposure may be 
used in PDT. 
A new medicinal aspect of phycobiliproteins and their 
antioxidant properties is their potential use in anti-aging 
research (reviewed in [120]). For instance, phycoerythrin 
purified from Lyngbia and applied as dietary supplement 
improved the mean life span, moderated the decline in aging-
associated physiological functions, enhanced stress 
tolerance, and also showed positive effects on an 
Alzheimer’s disease model in a transgenic Caenorhabditis 
elegans CL4176 model [137,138]. This anti-aging activity of 
the phycobiliproteins was clearly associated with their 
significant and dose-dependent antioxidant (hydroxyl-, 
superoxide and other various radical scavenging) and metal 
(Fe2+) chelating activity [137]. Interestingly, these systematic 
studies using the different phycobiliproteins isolated from 
Lyngbia have shown that phycoerythrin has the strongest 
hydroxyl and superoxide scavenging activity, while 
phycocyanin is the most potent Fe2+ chelator [137]. Cleary, 
the antioxidant activities of different phycobiliproteins 
(isolated from different organisms) and their chromophores 
have to be investigated and compared in different 
experimental settings. 
 
6.3.3. Photodynamic Therapy and Direct Anticancer 
Activities 
Several papers discuss the successful application of 
phycobiliproteins as photosensitizers (leading to the 
formation of reactive oxygen species and subsequent 
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apoptosis) in PDT of different tumor cells [157,162] using 
different light sources (e.g., helium-neon laser, argon ion 
laser, etc.). In vitro experiments have shown that 
phycoerythrin incorporated to liposome carriers had 
enhanced cellular uptake and photodynamic effect resulting 
in apoptosis in the HepG2 human hepatocellular carcinoma 
cell line [163]. Phycocyanin isolated from Microcystis was 
found to be localized to mitochondria of the same HepG2 
cell line in vitro, where it induced necrosis and apoptosis via 
mitochondria-dependent intrinsic pathway [122]. 
Phycoerythrin induced apoptosis in HeLa cell in vitro 
models when combined with PDT, and increased immunity 
and antioxidant ability also in Sarcoma-180 (S180) tumor-
bearing mice, in which it induced apoptosis by different 
cellular mechanisms (by increasing protease gene expression 
and tumor necrosis factor α secretion) [164]. Similarly, 
phycoeryhtrin and its subunits induced apoptosis and growth 
inhibition and a G0-G1 cell cycle arrest during PDT of mouse 
tumor cell line S180 and human liver carcinoma cell line 
SMC 7721 [165]. Both phycoerythrin and phycocyanin 
isolated from Porphyra yezoenis proved to be potential new 
photosensitizers for cancer PDT in the liver cancer cell line 
SMM C-7721 in vitro [166]. Phycocyanin-mediated PDT 
was shown to induce apoptosis and inhibit cell proliferation 
in a human breast adenocarcinoma (MCF-7) tumor model in 
mice and also in MCF-7 cell cultures [167]. Interestingly, in 
addition to its pro-apoptotic function (realized by the 
upregulation of pro-apoptotic proteins and downregulation of 
anti-apoptotic proteins in tumor cells) phycocyanin clearly 
had immune enhancing activity, which was only further 
enhanced by PDT [167]. This outlines the complex 
mechanism of PDT action on tumor cells. Due to its 
cytotoxic photosensibilization effect and specific binding to 
atherosclerotic plaques phycocyanin was shown to have a 
promising potential therapeutic use for atherosclerotic plaque 
localization and regression by PDT [121]. 
In addition to PDT, phycobiliproteins and phycobilins 
also have direct anticancer therapeutic effects which are 
often associated with the antioxidant and/or apoptosis 
inducing effects of these compounds. For instance, cancer 
cell proliferation was inhibited and apoptosis was induced in 
studies using (recombinant) phycocyanin in four different 
cancer cell lines [168]. Phycocyanin-induced apoptosis in a 
rat histiocytic AK-5 tumor cell line was shown to be possibly 
prompted by the generation of ROS and this apoptotic effect 
could be inhibited by ROS scavengers and the 
overexpression of Bcl-2, an apoptosis inhibitor [169]. 
Downregulation of the anti-apoptotic Bcl-2 was also shown 
to be one of the major molecular mechanisms of 
phycocyanin-induced apoptosis in both doxorubicin-
sensitive and resistant HepG2 hepatocellular carcinoma cell 
lines [125], human breast adenocarcinoma (MCF-7) cells 
[167], human HeLa cells [170], and in human chronic 
myeloid leukemia cell line K562 [124,171]. These in vitro 
studies have also shown that phycocyanin apparently enters 
the cytosol, where it exerts various other effects as well such 
as the release of cytochrome c from mitochondria to the 
cytosol, cleavage of poly(ADP) ribose polymerase 
[124,125], activation of caspase expression, decrease in 
membrane potential, upregulation of pro-apoptotic proteins 
[125,167,170]. But other anticancer mechanisms, including 
c-myc protein, may be responsible for the growth inhibition 
of K562 chronic myelogenous leukemia-blast crisis cells 
[172]. Selenium-containing phycocyanin effectively induced 
apoptosis both in A375 human melanoma and MCF-7 human 
breast adenocarcinoma cells by depletion of the 
mitochondrial membrane potential [153]. Similarly, the 
antioxidant and anti-proliferative activity of phycocyanin 
was demonstrated in vitro by induction of apoptosis (arrest 
in G0/G1 phase and DNA fragmentation) in colon cancer 
(HT-29) and lung adenocarcinoma (A549) cells in vitro 
[151]. 
High doses of phycocyanin from Limnothrix had 
antioxidant activity [173] and anticancer properties in in 
vitro studies [174]. At the same time, its co-administration 
with topotecan (a currently available anticancer drug) 
potentially improved the efficacy of the latter to generate 
ROS and to activate caspases involved in apoptosis induction 
and apoptosis in LNCaP prostate cancer cell line [174]. 
Similarly, phycocyanin inhibited the growth of HeLa cells in 
vitro, and effectively induced apoptosis and promoted 
complement-mediated cytolysis when co-administered with 
all-trans-retinoic acid [175]. These data show that co-
administration of phycobiliproteins with anticancer drugs 
may be effective in decreasing the needed drug 
concentrations, and thus, diminishing the harsh side effects 
of the latter in the patients, while keeping similarly efficient 
anticancer effects. 
Phycocyanin induced in a dosage dependent manner 
the expression of cluster of differentiation 59, of apoptosis-
inducing factors and simultaneously declined the 
multiplication of HeLa cells as a kind of mitosis depressor, 
but did not affect these parameters in normal Chinese 
hamster ovary cells [176], which outlines its potential 
application as a novel anti-tumor therapeutic agent. Extracts 
of Spirulina platensis as well as its tetrapyrrolic components 
(phycocyanobilin and as a water-soluble Chl derivative, 
copper-chlorophyllin) substantially decreased the 
proliferation of experimental pancreatic cancer cells both in 
vitro (using several human pancreatic cancer cell lines) and 
in vivo (in xenotransplanted nude mice) [177]. 
The expression of critical early proteins involved in 
tumorigenesis was induced by the exposure of mouse skin to 
12-O-tetradecanoyl-phorbol-13-acetate, however, the 
simultaneous presence of phycocyanin prevented these 
alterations in gene expression, further elucidating the large 
variety of mechanisms underlying the antitumor effects of 
this compound [178]. 
Most studies dealing with the direct anticancer effect 
of phycobiliproteins used phycocyanin, however, a mouse 
efficacy study of (recombinant) allophycocyanin showed 
remarkable inhibition of the S-180 carcinoma in mice [136 
cf. 135]. 
On the other hand, phycocyanin showed anti-
apoptotic effect in vivo in rats with tributyltin-induced 
thymic atrophy due to its natural antioxidant and Fe-
chelating capacity (see Section 6.3.2) which alleviated the 
oxidative stress mediated apoptosis in rat thymocytes in vivo 
[133]. 
Phycocyanin was effective in preventing galactose-
induced human lens epithelial cell (hLEC line SRA01/04) 
apoptosis in vitro through mitochondrial and unfolded 
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protein response pathways, an effect that may have 
therapeutic implications in preventing cataract formation 
[179]. 
These data potentate phycobiliproteins as promising 
agents in prevention or treatment of various diseases 
including first of all cancer but also other diseases involving 
apoptotic processes. In addition, as a result of their 
photodynamic properties and binding capacity to cancer 
cells, phycobiliproteins may be suitable for tumor 
colocalization in vivo [121,151]. 
 
6.3.4. Anti-inflammatory and Immunomodulatory effects 
Studies with so-called ‘protein fraction’ and isolated 
phycocyanin and phycoerythrin of Porphyra columbina have 
demonstrated that not the phycobiliproteins, but other factors 
are responsible for the immunomodulatory effect of the 
protein fraction [180]. However, there are several reports on 
the anti-inflammatory effect of phycobiliproteins. For 
instance, phycocyanin had anti-inflammatory effect similar 
to that of non-steroidal drugs and was, thus, effective in 
decreasing edema index in glucose-oxidase induced 
inflammation in mouse paw model [141], in carrageenan-
induced rat paw edema model (both in intact and 
adrenalectomized rats) [130], arachidonic acid- and 
tetradecanoylphorbol acetate-induced ear edema model in 
mice [130,181,182], and had inhibitory effect in the cotton 
pellet granuloma test in the rat axilla [130]. Topical 
administration of phycocyanin containing liposomes resulted 
in anti-inflammatory activity in croton-oil-induced or 
arachidonic acid-induced ear edema models in rats [183]. 
Phycocyanin also showed anti-inflammatory effect in 
a zymosan-induced experimental arthritis model in mice 
[184], in acetic acid induced colitis in rats [185] and in 
carrageenan-induced thermal hyperalgesia model where both 
its pre- or post-administration influenced nociception (rat 
paw withdrawal) showing its additional antihyperalgesic 
activity in this model [186]. Phycocyanin also inhibited 
allergic inflammatory response in a dose dependent manner 
in ovalbumin-induced edema model in mice as well as in 
other in vivo and in vitro models probably due to its 
inhibitory effect on histamine release from mast cells [187]. 
In vitro studies in lipopolysaccharide-stimulated RAW 264.7 
macrophages [188] or BV-2 microglial cells [189] indicated 
that phycocyanin inhibits nitrite production, tumor necrosis 
factor formation and NF-κB (nuclear factor kappa-light-
chain-enhancer of activated B cells) activation [188], 
decreases the cytotoxicity and inhibits the expression of 
inflammation-related genes [189]. In addition, the observed 
anti-inflammatory effects are probably due, at least in part, to 
the antioxidant and ROS scavenging effects of phycocyanin 
(see Section 6.3.2) [130,184,185], to its inhibitory effects on 
arachidonic acid metabolism and cytokine production, on 
tumor necrosis factor formation [184,188], leukotriene B4 
formation [181], and on prostaglandin E2 production and 
phospholipase A2 activity [182]. In vitro studies using 
isolated enzyme assays and whole blood assays have shown 
that even very low (nanomolar) concentrations of 
phycocyanin selectively inhibit cyclooxygenase type 2 
(COX-2) [190] which is upregulated during inflammation 
and cancer (especially breast cancer cells), and which in 
addition may also reduce prostaglandin E2 production [191]. 
This inhibitory effect may explain – at least in part – the 
anti-tumor, hepatoprotective, anti-arthritic and anti-
inflammatory effects of phycocyanin, as COX-2 inhibitors 
induce apoptosis in cancer cells and also in cells involved in 
inflammation (e.g., in lipopolysaccharide-stimulated RAW 
264.7 mouse macrophage cell lines in vitro [191]). 
Interestingly, the apoprotein part, and not the 
phycocyanobilin pigments, seemed to be responsible for the 
selective inhibition of COX-2 [190]. Works dealing with 
murine macrophage cell line J774A.1 have demonstrated that 
phycocyanin decreased the production of lipopolysaccharide-
induced ROS, but stimulated the secretion of inflammatory 
cytokines and boosted immunomodulation performance 
[192]. Posttreatment with phycocyanin alleviated lung 
edema and inflammation in a rat model of acute lung injury 
induced by intratracheally administered lipopolysaccharide 
by decreasing oxidative stress, and down- and upregulating 
pro- and anti-apoptotic proteins, respectively [193]. 
Dietary supplementation with phycocyanin was 
effective in reducing the tinnitus induced by intraperitoneally 
administered salicylate by downregulation of the expression 
of genes involved in inflammation (such as N-methyl D-
aspartate receptor, tumor necrosis factor-α, interleukin-1β, 
and cyclooxygenase type 2) in the cochlea and inferior 
colliculus of mice [194]. 
Experiments with mice orally immunized with 
antigen (ovalbumin)-entrapped biodegradable microparticles 
showed that previous administration of phycocyanin 
enhanced secretary IgA antibody response and functions of 
the mucosal immune system while reduced the allergic 
inflammation by the suppression of antigen-specific IgE 
antibody [195]. Phycocyanin and phycocyanobilin have the 
potential to boost T regulatory cell activity [196], and thus 
may have therapeutic potential in the management of 
inflammatory disorders and autoimmune or allergic 
syndromes [197]. 
 
6.3.5. Hepatoprotective and Nephroprotective Effects 
Single-dose intraperitoneal administration of 
phycocyanin significantly reduced the carbon tetrachloride 
(CCl4) and R-(1)-pulegone-induced hepatotoxicity in rats by 
providing protection to liver enzymes [134]. This effect was 
probably obtained by lowering the biotransformation of the 
hepatotoxins into toxic intermediates and the alleviation of 
oxidative stress by antioxidant activity (ability to scavenge 
haloalkane free radicals). Phycocyanin alleviated the carbon 
tetrachloride induced hepatocyte damage both in vitro (in 
L02 human hepatocyte cell line [198]) and in vivo in mice 
[198] or rats [199] by protecting the cells from free radical 
damage and oxidative stress [198,199], and inflammatory 
infiltration [198]. Similarly, intraperitoneal pre-
administration of phycocyanin effectively reduced the 
necrosis and inflammation during intraperitoneal 
galactosamine-induced hepatitis [200]. 
In other studies, orally administered phycoerythrin 
[201] or phycocyanin [202] along with intraperitoneally 
added carbon tetrachloride [201] or Na-oxalate [202] had 
similarly an ameliorative effect on hepatic [201] and renal 
[201,202] toxiticy symptoms in rats. Phycocyanin may also 
be useful to fight against oxalate-mediated nephronal 
impairment due to oxidative stress [202]. A mixture of 
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Arthrospira maxima phycobiliproteins as well as purified 
phycocyanin from the same species [203] and a mixture of 
phycobiliproteins (rich in phycoerythrin) and extracted from 
Pseudanabaena tenuis [204] protected rat renal cells against 
HgCl2-induced oxidative stress and cellular damage. 
Phycocyanin significantly decreased Kupffer cell 
phagocytosis and oxidative stress upon colloidal carbon 
uptake in isolated perfused mouse liver models [205]. 
The pharmacological effect is often attributed to the 
tetrapyrrole and to some extent bilirubin biotransformations 
as well as metabolic (dietary protein) actions of the 
phycoerythrin apoprotein [201]. Soni et al. [201] clearly 
demonstrated that the chromophore part (phycobilin 
pigment) got absorbed in the gut and metabolized leading to 
increased bilirubin concentration. Intragastric intubation of 
rats with gibberellic acid (a dangerous pesticide) and 
simultaneously administered phycocyanin improved the 
antioxidant defense system, liver enzymes and hepatocyte 
structure when compared to animals treated only with 
gibberellic acid [206]. 
Similarly, it has been shown that phycocyanobilin 
binds human serum albumin with high affinity and competes 
with bilirubin for binding on this protein, indicating that the 
pharmacokinetics of phycocyanobilin may be influenced by 
bilirubin plasma concentration [207]. 
Phycocyanobilin pigments metabolized to 
biliverdin/bilirubin homologs (phycocyanorubin) by for 
instance rat liver biliverdin reductase [208] inhibited 
NADPH oxidase activity (already at micromolar 
concentrations) [209]. Therefore, it has been hypothesized 
that their joint administration with genistein (a soy 
isoflavone) may prevent hepatic fibrosis in at-risk subjects 
[210]. 
Thioacetamide-induced hepatic encephalopathy of 
rats could be also ameliorated by co-administration of 
phycocyanin and subsequently improved antioxidant defense 
responses [211]. 
Intraperitoneally added phycocyanin alleviated the 
oxidative stress and nephrotoxicity caused by 
intraperitoneally administered cisplatin in mice, probably 
due to the ROS, RNS and hypochlorous acid scavenging 
activity of phycocyanin [144]. Similarly, due to its 
antioxidant activity, orally pre-administered single-dose 
phycocyanin protected the integrity of renal cells during 
nephrotoxicity induced by intraperitoneal oxalate injections 
in experimentally induced urolithic rats [212]. Phycocyanin 
efficiently protected the renal epithelial cell line (MDCK) 
against oxalate-mediated oxidative stress, lipid peroxidation 
and mitochondrial dysfunctions outlining its potential in 
treating oxidative stress-associated diseases like urolithiasis 
[213]. 
 
6.3.6. Neuroprotective Effects 
Phycocyanin was shown to prevent potassium/serum 
deprivation-induced apoptosis in rat cerebellar granule cell 
cultures probably due to its antioxidant effect [214], and may 
be, therefore, have some potential in treating Alzheimer’s 
and Parkinson’s diseases. Similarly, orally administered 
phycocyanin reached the brain parenchyma (and thus, it or 
its metabolites crossed the hemato-encephalic-barrier) in 
sufficient concentrations to reduce the neurotoxic impact 
(microglial and astroglial activation) of the excitotoxin 
kainine in rat hippocampus [128]. 
Phycocyanin may be also used as neuroprotector to 
treat experimental autoimmune encephalomyelitis in rats and 
multiple sclerosis (and other neurodegenerative disorders) by 
its antioxidant capacity and by inducing regulatory T cell 
response in peripheral blood mononuclear cells in humans 
[196]. 
Similarly, phycocyanin was shown to have 
neuroprotective effect against global cerebral 
ischemia/reperfusion (stroke) injury in gerbils both 
prophylactically or therapeutically by decreasing infarct 
volume, protecting against hippocampus neuronal cell death 
via its antioxidant activity (prevention of lipid peroxidation) 
[215]. Its neuroprotective effect was further demonstrated in 
vitro in tert-butylhydroperoxide-induced oxidative injury in 
SH-SY5Y neuroblastoma cells, in pressure/reperfusion 
induced transient ischemia in rat retinas and in 
calcium/phosphate induced impairment of isolated rat brain 
mitochondria where phycocyanin neuroprotection was 
realized by protecting mitochondria and reducing oxidative 
stress [216]. In SH-SY5Y neuroblastoma cells phycocyanin 
also exerted neuroprotective effect against iron-induced 
toxicity due to its chelating potential, and, thus, a decrease in 
iron-mediated ROS formation and neuropathology [129]. 
Taken together, and especially based on the activity 
of phycocyanobilin as antioxidant on the oxidative stress 
caused by peroxynitrite radicals and on NADPH oxidase, a 
key molecule contributing to the pathogenicity of activated 
brain microglia, oral phycocyanobilin may be useful in the 
treatment and/or prevention of various neurodegenerative 
disorders [217,218]. However, its anti-inflammatory and 
immuno-modulatory properties could also contribute to its 
neuroprotective properties [189,215]. 
 
6.3.7. Other Miscellaneous Medicinal Effects 
Phycocyanin has been identified and characterized as 
a novel and very potent antiplatelet agent (preventing the 
aggregation of platelets in vitro even at nanomolar 
concentrations) for treatment of arterial thromboembolism 
[219,220]. In addition to the confirmation of its scavenging 
activity on hydroxyl radicals released from activated 
platelets [219], it was also shown to inhibit several important 
processes leading to platelet aggregation [219,220]. 
Phycocyanin also exhibited profibrinolytic effect in calf 
pulmonary arterial endothelial cells which further outlines its 
potential use in prophylaxis against thrombotic vascular 
disorders [221]. 
Purified phycoerythrin protected human fibroblasts 
from KMnO4-mediated DNA damage [123]. Phycocyanin 
has been shown to be a potent wound-healing agent in vivo 
and in vitro that may be even used to heal internal wounds 
such as ulcer [222]. An isolated cysteine-rich cyanopeptide 
from Spirulina phycocyanin induced human lung fibroblast 
(TIG 3-20) migration to wounded area in an in vitro cell 
scratch injury assay suggesting its role in fibroblast 
proliferation and migration, and thus in wound healing and 
atherosclerosis among others [161]. 
Phycoerythrin also attenuated diabetic complications 
and Cu-mediated lipoprotein oxidation in streptozotocin-
nicotinamide-induced type 2 diabetic rats by reducing the 
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oxidative stress and the oxidized low-density lipoprotein-
triggered atherogenesis [139]. Phycocyanin protected the 
pancreatic islets from alloxan injury via different 
mechanisms (promoting glycogen synthesis in the liver, 
preventing oxidative stress in the liver, kidney and pancreas, 
decreasing cholesterol and triglyceride levels in the serum 
and the liver) showing the potential of this compound to 
prevent diabetes [132]. 
Similarly, oral administration of phycocyanin (300 
mg kg-1 for 10 weeks) and phycocyanobilin (15 mg kg-1 for 2 
weeks) in db/db mice, a rodent model for type 2 diabetes had 
clearly antioxidant properties preventing the animals from 
oxidative stress and renal dysfunction by various 
mechanisms including NADPH oxidase, thus, offering a 
novel and feasible therapeutic approach to prevent diabetic 
nephropathy [223]. The fact that phycocyanobilin had 
similar protective effect indicates that it may be responsible 
for this effect of the phycocyanin complex. In vitro models 
have shown that phycocyanin protected rat insulinoma beta 
cells (INS-1E) against human islet amyloid popypeptide 
(hIAPP) induced apoptosis by attenuating oxidative stress 
and modulating different signaling pathways [224]. As 
hIAPP aggregation plays an important role in the loss of 
insulin-producing pancreatic beta cells, these results outline 
the potential therapeutic importance of phycocyanin in the 
treatment or prevention of diabetes. 
In vitro experiments (on EA.hy926 endothelial cells) 
and in vivo experiments in mice have shown that 
phycocyanobilin (and Spirulina extracts) activated the 
atheroprotective heme oxygenase-1 (Hmox1) involved in the 
generation of bilirubin, a potent antioxidant, and also 
modulated other important markers of oxidative stress and 
endothelial disfunction (e.g., NADPH oxidase subunit) 
[225]. 
Oral administration of phycocyanin decreased the 
serum cholesterol concentration and atherogenic index, and 
thus, had a strong hypocholesterolemic effect in rats fed on 
high-cholesterol diet [226]. Similarly, chronic consumption 
of Se-rich or normal Spirulina phycocyanin powerfully 
prevented the development of atherosclerosis by decreasing 
oxidative stress and NADPH oxidase expression and 
improvement of the serum lipid profile in hamsters fed on 
atherogenic diet [209]. These data outline the potential of 
phycocyanin and phycocyanobilin in the reduction of 
atherosclerotic disease. 
Phycocyanin also had a preventive action on 
naphthalene and galactose [227] or Na-selenite [228] 
induced cataract models in rats due to its antioxidant and 
ROS scavenging activity [227] and, thus, its ability to 
prevent/alter secondary changes [228]. 
Similarly, it stimulated the lymphocyte enzymatic 
antioxidant defense system of nuclear power-plant workers 
upon irradiation, outlining its potential to protect 
occupationally exposed persons from radiation [229]. 
Phycocyanin also had cardioprotective effects. It 
alleviated the doxorubicin-induced oxidative stress and 
apoptosis of cardiomyocytes isolated from adult rat hearts 
[230] and attenuated the ischemia-reperfusion-induced 
myocardial injury and disfunction (enhanced the recovery of 
heart function and decreased the infarct size) in isolated 
perfused Langendorff rat heart model via its antioxidant, 
anti-apoptotic and signaling pathway modulatory effects 
[231]. 
Confocal immunofluorescence and immunoblot 
analyses have demonstrated that phycocyanin can enter 
B16F10 melanoma cells in vitro, where it exerts dual 
antimelanogenic effect, resulting in suppression of melanin 
synthesis [127]. This effect may be used in biomedicine and 
cosmetics for skin whitening (e.g., in case of abnormal 
hyperpigmentation). 
Phycocyanin inhibited the expression of the 
acetylaminofluorene-induced multidrug resistance protein 
(MDR1) in the mouse macrophage cell line RAW 264.7 in 
vitro by scavenging ROS [232] and in the liver of albino 
mice in vivo by interfering at the level of ROS generation, 
Akt (protein kinase B) phosphorylation and NF-κB 
translocation [233]. The same mechanisms (downregulation 
of ROS and COX-2 pathways via the involvement of NF-κB 
and activator protein 1 - AP-1, inhibition of MDR1) were 
confirmed in HepG2 human hepatocarcinoma cell line in 
relation to prevention of doxorubicin resistance by 
phycocyanin [126]. These data suggest that phycocyanin 
may be used to overcome drug and xenobiotic resistance in 
cellular systems [232] and to increase the sensitivity of cells 
to drugs (e.g., doxorubicin) [126]. It is noteworthy to 
mention, that phycocyanin did not interfere with the 
antineoplastic activity of the drug in human ovarian cancer 
cells [60,230]. 
Pre-, post- or simultaneously administered 
allophycocyanin was also shown to have antiviral effect: it 
delayed viral RNA synthesis in infected cells and neutralized 
the enterovirus 71-induced cytopathic (apoptotic) effect in 
human rhabdomyosarcoma and African green monkey 
kidney cell models [234]. 
 
6.4. Other Industrial Application of Tetrapyrrole 
Derivatives 
 
Phycobilisomes are genuinely organized 
photosynthetic antennae the chromophore components of 
which transfer the absorbed light energy towards their 
acceptors (and finally to Chl a in reaction centre cores) in a 
highly efficient manner. However, when extracted to 
aqueous buffer, phycobilisomes disintegrate, and the 
phycobiliproteins, and their bound chromophores lose their 
acceptors, and get rid of the absorbed light energy by 
intensive fluorescence emission. This, along with the fact 
that many chromophores are present in the hexameric 
phycobiliprotein complexes, explains the excellent 
fluorescence properties (extremely high quantum yields and 
molar extinction coefficients) of the pigments of 
phycobiliproteins when compared to other fluorophores [13]. 
The quantum yields (efficiencies) of phycoerythrin and 
allophycocyanin are 0.82 and 0.68, respectively, their 
extinction coefficients are 1,960,000 and 700,000 cm-1 M-1, 
respectively [235]. Another advantage of their use as 
fluorescent dyes is that they can be excited and emit in the 
red end of the visible spectrum, interfering this way less with 
other biological compounds and/or fluorescent dyes [61]. In 
addition, phycobiliproteins also have large Stokes shifts (of 
approx. 80 nm without significant interference with Rayleigh 
or Raman scatter or with other fluorescing compounds) 
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[61,73], and their apoprotein chains contain amino and 
carboxyl groups that enable their conjugation with other 
molecules [13]. Their quantum yields do not depend on pH 
[61], however, monomerization of phycobiliprotein 
hexamers and denaturation of the apoproteins result in strong 
decrease of the fluorescence intensity of the chromophores. 
The first fluorescence probes using phycobiliproteins 
were orange-red colored phycoerythrin-immunoglobulin, 
phycoerythrin-protein A, and phycoeryhtrin-avidin 
conjugates detectable at femtomol concentrations due to the 
high fluorescence yield of the chromophores [236]. Due to 
their advantageous properties, phycobiliproteins (especially 
phycoerythrin and allophycocyanin, and to a lesser extent 
cryptophyte-derived phycobiliproteins [237], and energy 
transfer tandem dyes of phycoerythrin and allophycocyanin 
[238]) are nowadays routinely used as preferred fluorescent 
dyes for applications that require either sensitivity or 
simultaneous multicolor detection [13,20,61,239–243]. 
These include clinical and immunological analyses, where 
phycobiliproteins are used to label antibodies, receptors or 
other molecules in fluorescence microscopy, 
immunolabelling, diagnostics, and fluorescence-activated 
cell sorters (flow cytometry). Unfortunately, the high 
molecular weight of phycobiliproteins (approx. 200 kDa) 
hinders their diffusion into cells of interest, and, thus limits 
their applicability [73]. However, discussing these data is 
beyond the scope of this review and is discussed in detail 
elsewhere [61]. 
 
7. CONCLUSIONS AND FUTURE PERSPECTIVES 
The consumers’ increasing demand in natural 
colorings represents a major problem for the food industry in 
case of green and blue hues and especially their water-
soluble forms. These are nowadays available only as water-
soluble Chl derivatives (E140ii and E141ii) facing 
compositional and nomenclatural problems and strict re-
evaluation in the European Union [7,244] and limited 
acceptance in the United States [80,245]. Therefore, the use 
of different phycobilins or phycobilin-containing products 
such as phycobiliproteins or spirulina extracts as coloring 
food will probably gain more importance in the upcoming 
years. 
However, to achieve this goal, the thermal, light and 
pH stability of the pigments and especially the 
phycobiliproteins, as well as their aqueous stability, and their 
alcohol resistance and shelf life have to be improved [61]. 
The rheological properties [246] and the interactions of the 
pigments with other substances and matrices like for instance 
preservatives [94,247] all need further studies. Similarly, the 
cultivation, extraction [75] and purification procedures 
yielding such commodities also need standardization and 
further optimization. 
For low-cost industrial production of phycobilins (and 
to a lesser extent Chls and also carotenoids) usually outdoor, 
photoautotrophic growth of cyanobacterial and/or red algal 
cultures are used in tropical and subtropical regions (Fig. 5). 
However, myxotrophic and heterotrophic algal cultures (the 
latter using for instance Galdieria sulphuraria [13,248]) may 
be also considered, as well as recombinant protein 
production in different organisms [13] (e.g., Escherichia coli 
[135,147,249,250], Streptomyces [251] and Chlamydomonas 
reinhardtii [252]). Photobioreactors of different types (e.g., 
designed flat-type photobioreactor [253], airlift tubular 
photobioreactor [254]) are being developed for industrial 
scale production to simultaneously enhance phycocyanin 
production and CO2 fixation [253]. Other perspective future 
directions include the valorization of industrial polluting 
byproducts (e.g., beet vinasse, a byproduct of molasses 
fermentation factories) for Spirulina cultivation [254], and 
the use of Spirulina cultures to fix and, thus, decrease CO2 
emissions from power plant flue gas [192,253]. 
1. Concerning the health and medicinal effects of 
phycobiliproteins and phycobilins, strictly, consistently and 
carefully planned and evaluated long-term experiments are 
needed to assess the relevance of the different in vitro data in 
vivo in humans. To this aim, the mechanisms of digestion, 
absorption, transport, metabolization, potential toxicity and 
the interactions of these various compounds and processes 
need to be better understood. 
At the same time, the therapeutic potentials of 
phycobiliproteins and phycobilins were in general tested for 
phycocyanin and/or phycocyanobilin obtained from 
Spirulina, while phycobiliproteins and phycobilins (e.g., also 
allophycocyanin [255] and phycoerythrin [77,85–
88,90,164]) obtained from other cyanobacteria (e.g., 
Anabaena marina [92], Aphanizomenon flos-aquae [117], 
Limnothrix [173,174], Lyngbya [142], Myxosarcina 
concinna [255], Microcystis [122], Oscillatoria tenuis [151], 
Phormidium fragile [256], Phormidium tenue [139,142,201] 
or Pseudanabaena tenuis [204]) or red algae (Corallina 
elongata [86], Heterosiphonia japonica [87], Polysiphonia 
urceolata [85,88], Porphyra yezoensis [166], Porphyra 
haitanensis [164], Porphyridium purpureum [76] or 
Porphyridium cruentum [90]) and other species may also 
have similar (or other) potential, and thus, require further 
studies. Isolated peptides of phycocyanins may also have 
therapeutical potential as they had antioxidant activity and 
inhibited the ROS induced DNA damage in vitro [161]. 
Similarly, studies showing the high potency of co-
administration of phycobiliproteins with low doses of 
existing anticancer or other drugs may open up new 
perspectives in the prevention and/or treatment of various 
diseases. Studies aimed at microencapsulation of 
phycocyanin [183,257] and phycoerythrin [163] in alginate 
and chitozan as coating materials [257] and in liposomes 
[163,183] as well as optimizing its release profile are already 
going on. This clearly outlines the great interest of the of the 
pharmaceutical industry in these compounds. Several patents 
and constantly developed expensive phycobiliprotein-
conjugated fluorescent dyes for flow cytometry and 
antibodies for immunolabelling show the great potential of 
these products in these other areas as well [61,258]. 
Clearly, in addition to their role in photosynthetic 
light capture in some photosynthetic pro- and eukaryotes, 
phycobilins and phycobiliproteins have also the potential as 
healthy natural food colorings or coloring food, as 
fluorescent dyes and also in medicine. Further research and 
the upcoming years will tell us how much and in which 
forms they can be best used by the food industry and 
medicine. 
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Chl = chlorophyll 
COX-2 = cyclooxygenase type 2 
NF-κB = nuclear factor kappa-light-chain-enhancer of 
activated B cells 
PDT = photodynamic therapy 
PROTO IX = protoporphyrin IX 
PSII = photosystem II 
RNS = reactive nitrogen species 
ROS = reactive oxygen species 
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